Our Mission
The mission of PleoPharma is to provide therapies for those individuals seeking treatment for their addictions where no FDA approved product or medical treatment exists today.
Our goal is to develop safe and effective products to help treat these very real and often debilitating medical conditions.
What we do
PleoPharma is an ethical pharmaceutical development company focused on finding safe and effective FDA approved treatments for substance use disorders where therapies are lacking.
PleoPharma’s
Business Strategy
PleoPharma’s strategy is to develop novel FDA approved medications to treat addiction/withdrawal where there are currently no FDA approved therapies.
We believe this strategy offers the potential to make a meaningful contribution to our society while providing significant shareholder appreciation and value.
PleoPharma’s first to market strategy can enable significant commercial value for new indications designed to treat well-established addiction diseases where no therapy exists today.
We call this therapeutic void a “white space”.
Filling this white space through first to market new therapies typically enables strong Payor coverage and ensures a healthy and viable commercial opportunity.
